Document Type
Book Chapter
Rights
Available under a Creative Commons Attribution Non-Commercial Share Alike 4.0 International Licence
Abstract
In the United States, approximately 17,000 people per year are diagnosed with brain tumors, the leading cause of death from cancers in children ages 1-15 year (1,2). Gliomas are the most prevalent type of brain tumors in adults, affecting 3.2/100,000 persons/yr in the United States (www.CBTRUS.org). In spite of advances in surgery, chemotherapy, and radiotherapy, the mean survival time of patients post-diagnosis remains approximately 9-12 months.
DOI
https://doi.org/10.21427/e3bq-qp57
Recommended Citation
Castro, M.G., Curtin, J.F. & King, G.D., (2006). Novel Gene Therapeutic Approaches to Brain Cancer. Gene Therapy for Neurological Disorders, Chapter 13. (Taylor & Francis Group). doi:10.21427/e3bq-qp57
Funder
National Institute of Health, Bram and Elaine Goldsmith Chair in Gene Therapeutics, The Linda Tallen and David Paul Kane Annual Fellowship, Board of Governors at Cedars Sinai Medical Center.
Publication Details
Gene Therapy for Neurological Disorders Chapter 13 ISBN-10 : 0-8247-2847-5( Hardcover) ISBN-13: 978-0-8247-2847-2(Hardcover)